References
Whyte MP (2016) Hypophosphatasia—aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol 12(4):233–246
Whyte MP (2017) Hypophosphatasia: An overview for 2017. Bone
Bowden SA, Adler BH (2017) Asfotase alfa treatment for 1 year in a 16 year-old male with severe childhood hypophosphatasia. Osteoporos Int
STRENSIQ™ (asfotase alfa) [prescribing information]. Cheshire, CT: Alexion Pharmaceuticals, Inc; 2015. Available from: http://www.alexion.com/Documents/Strensiq_USPI.aspx
Millán JL (2013) The role of phosphatases in the initiation of skeletal mineralization. Calcif Tissue Int 93(4):299–306
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bowden, S.A., Adler, B.H. Reappearance of hypomineralized bone after discontinuation of asfotase alfa treatment for severe childhood hypophosphatasia. Osteoporos Int 29, 2155–2156 (2018). https://doi.org/10.1007/s00198-018-4613-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-018-4613-7